A nine-year old licencing deal signed on behalf of WA medical researchers is continuing to deliver returns, with US company Sarepta Therapeutics paying $11.5 million in royalties last year.

A nine-year old licencing deal signed on behalf of WA medical researchers is continuing to deliver returns, with US company Sarepta Therapeutics paying $11.5 million in royalties last year.